Table 6 Haplogroups association with breast cancer patients and controls.
Haplogroups | Total, n (%) | Cases, n (%) | Controls, n (%) | OR (95% CI) |
|---|---|---|---|---|
M | 46 (35.1) | 33 (46.5) | 13 (21.7) | Reference |
U | 41 (31.3) | 10 (14.1) | 31 (51.7) | 7.87 (3.02–20.54) |
H | 14 (10.7) | 11 (15.5) | 3 (5.0) | 1.44 (0.35–6.03) |
R | 12 (9.2) | 7 (9.9) | 5 (8.3) | 1.81 (0.49–6.75) |
J | 7 (5.3) | 5 (7.0) | 2 (3.3) | 0.49 (0.17–5.73) |
T | 4 (3.1) | 2 (2.8) | 2 (3.3) | 2.54 (0.32–19.96) |
N | 2 (1.4) | 1 (1.4) | 1 (1.7) | 2.54 (0.15–43.67) |
F | 1 (0.8) | 1 (1.4) | – | – |
S | 1 (0.8) | – | 1 (1.7) | – |
W | 3 (2.3) | 1 (1.4) | 2 (3.3) | 5.08 (0.42–60.92) |
